Published in Epidemics on June 01, 2010
Serotype replacement in disease after pneumococcal vaccination. Lancet (2011) 7.14
Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet (2013) 2.63
Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med (2011) 2.59
Dense genomic sampling identifies highways of pneumococcal recombination. Nat Genet (2014) 2.51
Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health (2014) 1.94
Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. PLoS Med (2011) 1.54
Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science (2012) 1.39
Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development. PLoS Negl Trop Dis (2011) 1.27
Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy. J Clin Microbiol (2012) 1.24
Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine (2011) 1.22
Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model. Epidemiology (2012) 1.20
Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerg Infect Dis (2014) 1.08
Vacated niches, competitive release and the community ecology of pathogen eradication. Philos Trans R Soc Lond B Biol Sci (2013) 1.06
Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study. PLoS One (2015) 1.05
Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination. PLoS Med (2016) 0.99
Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction. Vaccine (2015) 0.99
Surface charge of Streptococcus pneumoniae predicts serotype distribution. Infect Immun (2013) 0.96
Mechanisms of genome evolution of Streptococcus. Infect Genet Evol (2014) 0.92
A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella. Eur J Clin Microbiol Infect Dis (2012) 0.91
Selective and genetic constraints on pneumococcal serotype switching. PLoS Genet (2015) 0.90
Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine. Clin Vaccine Immunol (2010) 0.87
Pneumococcal transmission and disease in silico: a microsimulation model of the indirect effects of vaccination. PLoS One (2013) 0.87
Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trial. PLoS One (2013) 0.85
Pathogen evolution and the immunological niche. Ann N Y Acad Sci (2014) 0.85
Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines. Sci Rep (2016) 0.83
Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement. Hum Vaccin Immunother (2016) 0.83
Recombination in Streptococcus pneumoniae Lineages Increase with Carriage Duration and Size of the Polysaccharide Capsule. MBio (2016) 0.83
Optimal serotype compositions for Pneumococcal conjugate vaccination under serotype replacement. PLoS Comput Biol (2014) 0.82
Nasopharyngeal carriage of pneumococci four years after community-wide vaccination with PCV-7 in The Gambia: long-term evaluation of a cluster randomized trial. PLoS One (2013) 0.81
High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction. BMC Infect Dis (2016) 0.80
Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced. BMC Infect Dis (2015) 0.79
Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology. Braz J Med Biol Res (2011) 0.79
Pneumococcal Serotypes Colonise the Nasopharynx in Children at Different Densities. PLoS One (2016) 0.78
Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule. Eur J Pediatr (2013) 0.77
Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia. Vaccine (2015) 0.77
Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci. J Immunol Res (2015) 0.75
Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial. PLoS One (2014) 0.75
Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics. Clin Infect Dis (2016) 0.75
Genomic epidemiology of penicillin non-susceptible pneumococci with non-vaccine serotypes causing invasive disease in the USA. J Clin Microbiol (2017) 0.75
Pre-vaccine serotype composition within a lineage signposts its serotype replacement - a carriage study over 7 years following pneumococcal conjugate vaccine use in the UK. Microb Genom (2017) 0.75
Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: a longitudinal analysis of a case-control study. Microbiome (2017) 0.75
A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology (1998) 17.05
Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med (2001) 10.56
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis (2007) 6.45
Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis (2003) 5.73
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA (2005) 5.29
Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep (2005) 4.39
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis (2005) 4.16
Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J (2007) 3.99
Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics (2005) 3.42
Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics (2009) 3.32
Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis (2008) 2.70
Neutral microepidemic evolution of bacterial pathogens. Proc Natl Acad Sci U S A (2005) 2.42
Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis (2009) 2.36
Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides. Infect Immun (2003) 2.28
Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet (2000) 2.24
Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin Infect Dis (2004) 2.08
Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis (2006) 1.99
Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J (2004) 1.96
Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol (2003) 1.78
Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect Immun (2004) 1.55
Serotype-specific problems associated with pneumococcal conjugate vaccination. Future Microbiol (2008) 1.32
Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature (2005) 30.92
Strategies for mitigating an influenza pandemic. Nature (2006) 25.20
Targeted versus universal decolonization to prevent ICU infection. N Engl J Med (2013) 13.05
Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science (2003) 12.26
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (2003) 10.74
Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09
Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A (2008) 8.27
Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ (2009) 6.66
Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65
HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol (2007) 6.19
Prescription drug use in pregnancy. Am J Obstet Gynecol (2004) 4.92
Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med (2012) 4.19
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J (2007) 3.99
Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr (2007) 3.89
Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med (2006) 3.86
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79
Use of automated ambulatory-care encounter records for detection of acute illness clusters, including potential bioterrorism events. Emerg Infect Dis (2002) 3.79
Public health. Public health risk from the avian H5N1 influenza epidemic. Science (2004) 3.71
Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol (2007) 3.57
Fuzzy species among recombinogenic bacteria. BMC Biol (2005) 3.47
Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics (2005) 3.42
Host immunity and synchronized epidemics of syphilis across the United States. Nature (2005) 3.34
Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics (2009) 3.32
New strategies for the elimination of polio from India. Science (2006) 3.27
CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr (2007) 3.18
West African Ebola epidemic after one year--slowing but not yet under control. N Engl J Med (2014) 2.96
Racial/ethnic differences in early-life risk factors for childhood obesity. Pediatrics (2010) 2.73
Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis (2008) 2.70
Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet (2013) 2.63
Seasonal infectious disease epidemiology. Proc Biol Sci (2006) 2.62
Decreasing prevalence of obesity among young children in Massachusetts from 2004 to 2008. Pediatrics (2012) 2.58
Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2006) 2.57
Hyper-recombination, diversity, and antibiotic resistance in pneumococcus. Science (2009) 2.54
Racial/ethnic variation in asthma status and management practices among children in managed medicaid. Pediatrics (2002) 2.54
Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice. J Epidemiol Community Health (2006) 2.47
Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci (2004) 2.45
Health care use and decision making among lower-income families in high-deductible health plans. Arch Intern Med (2010) 2.37
The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med (2004) 2.36
Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis (2009) 2.36
Assessing the reliability of eBURST using simulated populations with known ancestry. BMC Microbiol (2007) 2.36
Mathematical models of infectious disease transmission. Nat Rev Microbiol (2008) 2.32
Multivariate scan statistics for disease surveillance. Stat Med (2007) 2.27
A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS (2008) 2.25
HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response. J Immunol (2005) 2.24
The potential regional impact of contact precaution use in nursing homes to control methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2012) 2.22
Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care (2007) 2.22
Ebola virus disease among children in West Africa. N Engl J Med (2015) 2.17
Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med (2012) 2.17
Effect of a pediatric hospitalist system on housestaff education and experience. Arch Pediatr Adolesc Med (2002) 2.15
Descriptive epidemiology and attributable morbidity of ventilator-associated events. Infect Control Hosp Epidemiol (2014) 2.15
Syndromic surveillance using minimum transfer of identifiable data: the example of the National Bioterrorism Syndromic Surveillance Demonstration Program. J Urban Health (2003) 2.15
Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J (2009) 2.12
Crossing growth percentiles in infancy and risk of obesity in childhood. Arch Pediatr Adolesc Med (2011) 2.11
Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics (2004) 2.08
Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine (2011) 2.03
Preparing medical students for the continual improvement of health and health care: Abraham Flexner and the new "public interest". Acad Med (2010) 2.00
Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis (2006) 1.99
The impact of homologous recombination on the generation of diversity in bacteria. J Theor Biol (2005) 1.99
Race differences in long-term diabetes management in an HMO. Diabetes Care (2005) 1.98
Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis (2012) 1.98
Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis (2006) 1.97
Developmental origins of childhood overweight: potential public health impact. Obesity (Silver Spring) (2008) 1.96
A new framework and software to estimate time-varying reproduction numbers during epidemics. Am J Epidemiol (2013) 1.94
Vitamin D deficiency in pregnancy and gestational diabetes mellitus. Am J Obstet Gynecol (2012) 1.93
A trial of disclosing physicians' financial incentives to patients. Arch Intern Med (2006) 1.91
Modeling community- and individual-level effects of child-care center attendance on pneumococcal carriage. Clin Infect Dis (2005) 1.91
Sequences, sequence clusters and bacterial species. Philos Trans R Soc Lond B Biol Sci (2006) 1.91
Longitudinal study of birth weight and adult body mass index in predicting risk of coronary heart disease and stroke in women. BMJ (2005) 1.90
Antibiotic treatment of children with sore throat. JAMA (2005) 1.90
Identifying currents in the gene pool for bacterial populations using an integrative approach. PLoS Comput Biol (2009) 1.89
The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom. PLoS Curr (2009) 1.87
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med (2010) 1.83
Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data. Epidemiology (2015) 1.83
Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics (2004) 1.82
Rapid and reproducible surveillance for ventilator-associated pneumonia. Clin Infect Dis (2012) 1.81
Medical education for a healthier population: reflections on the Flexner Report from a public health perspective. Acad Med (2010) 1.80
Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol (2008) 1.78
Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis (2008) 1.77
HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? PLoS Med (2012) 1.76
The effect of hospital volume of pediatric appendectomies on the misdiagnosis of appendicitis in children. Pediatrics (2004) 1.76
Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc Natl Acad Sci U S A (2003) 1.75
Reporting surgical site infections following total hip and knee arthroplasty: impact of limiting surveillance to the operative hospital. Clin Infect Dis (2013) 1.75
Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf (2006) 1.73